June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Photobiomodulation by 670nm light protects against oxidative stress in multiple organs in a rodent model of diabetes mellitus
Author Affiliations & Notes
  • Johnny Tang
    Department of Ophthalmology, The University of Kansas Medical Center, Kansas City, KS
  • Yunpeng Du
    Department of Pharmacology, Case Western Reserve University, Cleveland, OH
  • Jinwhan Lim
    National Institutes of Health, Bethesda, MD
  • Sandeep Gopalakrishnan
    Department of Public and Environmental Affairs, Indiana University, Bloomington, IN
  • Janis Eells
    Department of Biomedical Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI
  • Diane Henshel
    Department of Public and Environmental Affairs, Indiana University, Bloomington, IN
  • John Watkins
    School of Pharmacology and Toxicology, Indiana University, Bloomington, IN
  • Timothy Kern
    Department of Pharmacology, Case Western Reserve University, Cleveland, OH
    Research Services, Louis Stokes VA Medical Center, Cleveland, OH
  • Footnotes
    Commercial Relationships Johnny Tang, None; Yunpeng Du, None; Jinwhan Lim, None; Sandeep Gopalakrishnan, None; Janis Eells, QBMI Photomedicine (C); Diane Henshel, None; John Watkins, None; Timothy Kern, Bausch & Lomb (F), PamLab (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 1768. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Johnny Tang, Yunpeng Du, Jinwhan Lim, Sandeep Gopalakrishnan, Janis Eells, Diane Henshel, John Watkins, Timothy Kern; Photobiomodulation by 670nm light protects against oxidative stress in multiple organs in a rodent model of diabetes mellitus. Invest. Ophthalmol. Vis. Sci. 2013;54(15):1768.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Photobiomodulation (PBM) by light in the far-red to near-infrared range of the spectrum has been shown to have therapeutic benefit in experimental and clinical disease. We have demonstrated the usefulness of PBM on early lesions in diabetic retinopathy. This study evaluates the effects of PBM on heart, kidney, peripheral nerves and bone marrow in diabetes.

Methods: Methods: Animals were assigned to 3 groups, nondiabetic controls and diabetic animals with or without PBM treatment (25 mW/cm2, 200-300 secs, 5-7.5 J/cm2). Animals were handled in accordance with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the National Institutes of Health. All experimental procedures were reviewed and approved by the Case Western Reserve University and University of Wisconsin-Milwaukee Institutional Animal Care and Use Committee.

Results: Diabetic rats exhibited increased oxidative stress and dysfunction in retina, kidney, bone marrow and heart. PBM therapy significantly improved these parameters. In the retina and bone marrow, PBM significantly inhibited the diabetes-induced production of superoxide and normalized MnSOD expression in-vivo. In the heart PBM protected against total antioxidant loss and diabetes-induced reduction of catalase and thioredoxin activity in the heart. In the kidney, PBM improved kidney function, and increased catalase and Na K-ATPase activity. Allodynia was also attenuated following PBM treatment.

Conclusions: PBM offers a brief and noninvasive method to inhibit the development of retinal dysfunction and several biochemical changes characteristic of diabetes in different organ systems.

Keywords: 499 diabetic retinopathy • 695 retinal degenerations: cell biology • 634 oxidation/oxidative or free radical damage  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×